^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    TGFBI promoter hypermethylation

    i
    Other names: TGFBI, Transforming Growth Factor Beta Induced, Transforming Growth Factor-Beta-Induced Protein Ig-H3, Transforming Growth Factor, Beta-Induced, 68kD, RGD-Containing Collagen-Associated Protein, Kerato-Epithelin, Beta Ig-H3, RGD-CAP, BIGH3, Transforming Growth Factor, Beta-Induced, 68kDa, Transforming Growth Factor Beta-Induced 68kDa, Betaig-H3, CDGG1, CDB1, CDG2, EBMD, CSD1, CSD2, CSD3, LCD1, CSD
    Entrez ID:
    7045
    almost6years
    [VIRTUAL] TGFBI promoter methylation validation as an epigenetic biomarker for trastuzumab resistance in HER2+ breast cancer patients cohort (ESMO-BC-I 2020)
    These preliminary results provide a basis for further studies to validate TGFBI hypermethylation as a potential epigenetic monitoring biomarker for trastuzumab resistance in HER2+ BC patients.Legal entity responsible for the study: University of Girona and Catalan Institute of Oncology (ICO), Dr. Josep Trueta Hospital. Funding: University of Girona.
    Clinical
    |
    HER-2 (Human epidermal growth factor receptor 2) • TGFBI (Transforming Growth Factor Beta Induced)
    |
    HER-2 positive • TGFBI promoter hypermethylation
    |
    Herceptin (trastuzumab)
    almost6years
    [VIRTUAL] TGFBI promoter methylation validation as an epigenetic biomarker for trastuzumab resistance in HER2+ breast cancer patients cohort (ESMO-BC-I 2020)
    These preliminary results provide a basis for further studies to validate TGFBI hypermethylation as a potential epigenetic monitoring biomarker for trastuzumab resistance in HER2+ BC patients.Legal entity responsible for the study: University of Girona and Catalan Institute of Oncology (ICO), Dr. Josep Trueta Hospital. Funding: University of Girona.
    Clinical
    |
    HER-2 (Human epidermal growth factor receptor 2) • TGFBI (Transforming Growth Factor Beta Induced)
    |
    HER-2 positive • TGFBI promoter hypermethylation
    |
    Herceptin (trastuzumab)